Cite

HARVARD Citation

    Adams, D. et al. (2020). Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor. Toxicologic pathology. pp. 362-378. [Online]. 
  
Back to record